Replies to post #2883 on Synaptogenix Inc (SNPX)

[InTheTrenches]

Good point, RE: "fresh frozen blinded Alzheimer's brains". (Wow, does that sound disgusting :-) )

I'm glad as well for this phase 2b trial design. If results similar to the compassionate-use patients, will be very difficult to question, except for the longevity of the trial.

Should also quickly get FDA approval for the open-label extension study for the 150 p2b patients.